Mental Health & Depression: 82 new trials, 3,269 recruiting, 1,127 papers published, April 13–20, 3509 off-label use reports.
Doctiplus - We are allways here!
Doctiplus - We are allways here!
Mental Health & Depression: 82 new trials, 3,269 recruiting, 1,127 papers published, April 13–20, 3509 off-label use reports.
Cancer & Oncology: 232 new trials, 18,739 recruiting, 3,343 papers published, April 13-20, Off Label Use tops 8,459 reports.
Diabetes: 40 new trials, 2,013 recruiting, 1,415 papers published. Off-label use tops adverse reports at 9,832. April 13–20.
Heart Disease & Cardiovascular: 135 new trials, 8,710 recruiting, 1,697 papers published, Fatigue tops adverse reports at 6,351, April 13–20.
Dementia & Alzheimer’s: 14 new trials, 949 recruiting, 1 Phase 3 trial. 1,394 papers published, 619 death reports. April 13-20.
Mental Health & Depression: 82 new trials, 3,269 recruiting, 1,171 papers published, April 11–18, 3509 off-label use reports.
Cancer & Oncology: 232 new trials, 18,739 recruiting, 3,526 papers published, April 11–18, Off Label Use tops 8,459 reports.
Diabetes: 40 new trials, 2,013 recruiting, 1,447 papers published. Off-label use tops adverse reports at 9832. April 11–18.
Heart Disease & Cardiovascular: 135 new trials, 8,710 recruiting, 1,749 papers published, fatigue tops adverse reports at 6,351. April 11-18.
Dementia & Alzheimer’s: 14 new trials, 949 recruiting, 1,439 papers published, 619 death reports. April 11-18.